OperaV1, PubMed, Curation, bibRecord, 000169

Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study.

Identifieur interne : 000169 ( PubMed/Curation ); précédent : 000168; suivant : 000170

Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study.

Auteurs : Pauliina Pisto [Finlande] ; Merja Santaniemi ; Risto Bloigu ; Olavi Ukkola ; Y Antero Kes Niemi

Source :

BMJ open ; 2014.

RBID : pubmed:24650811

English descriptors

KwdEn :
- Cardiovascular Diseases (epidemiology), Cardiovascular Diseases (mortality), Female, Follow-Up Studies, Humans, Incidence, Kaplan-Meier Estimate, Male, Middle Aged, Non-alcoholic Fatty Liver Disease (complications), Non-alcoholic Fatty Liver Disease (ultrasonography), Population Surveillance, Risk Factors.
MESH :
- complications : Non-alcoholic Fatty Liver Disease.
- epidemiology : Cardiovascular Diseases.
- mortality : Cardiovascular Diseases.
- ultrasonography : Non-alcoholic Fatty Liver Disease.
- Female, Follow-Up Studies, Humans, Incidence, Kaplan-Meier Estimate, Male, Middle Aged, Population Surveillance, Risk Factors.

Abstract

We investigated if the differences in liver fat content would predict the development of non-fatal and fatal atherosclerotic endpoints (coronary heart disease and stroke).

DOI: 10.1136/bmjopen-2014-004973
PubMed: 24650811

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000169

Links to Exploration step

pubmed:24650811

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study.</title>
<author><name sortKey="Pisto, Pauliina" sort="Pisto, Pauliina" uniqKey="Pisto P" first="Pauliina" last="Pisto">Pauliina Pisto</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine and Biocenter Oulu, Institute of Clinical Medicine, University of Oulu, and Clinical Research Center, Oulu University Hospital, Oulu, Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Department of Internal Medicine and Biocenter Oulu, Institute of Clinical Medicine, University of Oulu, and Clinical Research Center, Oulu University Hospital, Oulu</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Santaniemi, Merja" sort="Santaniemi, Merja" uniqKey="Santaniemi M" first="Merja" last="Santaniemi">Merja Santaniemi</name>
</author>
<author><name sortKey="Bloigu, Risto" sort="Bloigu, Risto" uniqKey="Bloigu R" first="Risto" last="Bloigu">Risto Bloigu</name>
</author>
<author><name sortKey="Ukkola, Olavi" sort="Ukkola, Olavi" uniqKey="Ukkola O" first="Olavi" last="Ukkola">Olavi Ukkola</name>
</author>
<author><name sortKey="Kes Niemi, Y Antero" sort="Kes Niemi, Y Antero" uniqKey="Kes Niemi Y" first="Y Antero" last="Kes Niemi">Y Antero Kes Niemi</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="doi">10.1136/bmjopen-2014-004973</idno>
<idno type="RBID">pubmed:24650811</idno>
<idno type="pmid">24650811</idno>
<idno type="wicri:Area/PubMed/Corpus">000169</idno>
<idno type="wicri:Area/PubMed/Curation">000169</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study.</title>
<author><name sortKey="Pisto, Pauliina" sort="Pisto, Pauliina" uniqKey="Pisto P" first="Pauliina" last="Pisto">Pauliina Pisto</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine and Biocenter Oulu, Institute of Clinical Medicine, University of Oulu, and Clinical Research Center, Oulu University Hospital, Oulu, Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Department of Internal Medicine and Biocenter Oulu, Institute of Clinical Medicine, University of Oulu, and Clinical Research Center, Oulu University Hospital, Oulu</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Santaniemi, Merja" sort="Santaniemi, Merja" uniqKey="Santaniemi M" first="Merja" last="Santaniemi">Merja Santaniemi</name>
</author>
<author><name sortKey="Bloigu, Risto" sort="Bloigu, Risto" uniqKey="Bloigu R" first="Risto" last="Bloigu">Risto Bloigu</name>
</author>
<author><name sortKey="Ukkola, Olavi" sort="Ukkola, Olavi" uniqKey="Ukkola O" first="Olavi" last="Ukkola">Olavi Ukkola</name>
</author>
<author><name sortKey="Kes Niemi, Y Antero" sort="Kes Niemi, Y Antero" uniqKey="Kes Niemi Y" first="Y Antero" last="Kes Niemi">Y Antero Kes Niemi</name>
</author>
</analytic>
<series><title level="j">BMJ open</title>
<idno type="e-ISSN">2044-6055</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cardiovascular Diseases (epidemiology)</term>
<term>Cardiovascular Diseases (mortality)</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Incidence</term>
<term>Kaplan-Meier Estimate</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Non-alcoholic Fatty Liver Disease (complications)</term>
<term>Non-alcoholic Fatty Liver Disease (ultrasonography)</term>
<term>Population Surveillance</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Non-alcoholic Fatty Liver Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Cardiovascular Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Cardiovascular Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="ultrasonography" xml:lang="en"><term>Non-alcoholic Fatty Liver Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Incidence</term>
<term>Kaplan-Meier Estimate</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Population Surveillance</term>
<term>Risk Factors</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We investigated if the differences in liver fat content would predict the development of non-fatal and fatal atherosclerotic endpoints (coronary heart disease and stroke).</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">24650811</PMID>
<DateCreated><Year>2014</Year>
<Month>03</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted><Year>2016</Year>
<Month>01</Month>
<Day>27</Day>
</DateCompleted>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN>
<JournalIssue CitedMedium="Print"><Volume>4</Volume>
<Issue>3</Issue>
<PubDate><Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>BMJ open</Title>
<ISOAbbreviation>BMJ Open</ISOAbbreviation>
</Journal>
<ArticleTitle>Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study.</ArticleTitle>
<Pagination><MedlinePgn>e004973</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2014-004973</ELocationID>
<Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We investigated if the differences in liver fat content would predict the development of non-fatal and fatal atherosclerotic endpoints (coronary heart disease and stroke).</AbstractText>
<AbstractText Label="DESIGN, SETTING AND PARTICIPANTS" NlmCategory="METHODS">Our study group is a population-based, randomly recruited cohort (Oulu Project Elucidating Risk of Atherosclerosis, OPERA), initiated in 1991. The cohort consisted of 988 middle-aged Finnish participants.</AbstractText>
<AbstractText Label="INTERVENTION" NlmCategory="METHODS">Total mortality and hospital events were followed up to 2009 based on the registry of the National Institute for Health and Welfare and the National death registry.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE" NlmCategory="METHODS">The severity of hepatic steatosis was measured by ultrasound and divided into three groups (0-2). Cox regression analysis was used in the statistical analysis.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In the follow-up of years 1991-2009, 13.5% of the participants with non-fatty liver, 24.2% of participants having moderate liver fat content and 29.2% of the participants having severe fatty liver experienced a cardiovascular event during the follow-up time (p<0.001). Severe liver fat content predicted the risk for future risk of cardiovascular event even when adjusted for age, gender and study group (HR 1.92, CI 1.32 to 2.80, p<0.01). When further adjustments for smoking, alcohol consumption, low-density lipoprotein-cholesterol, body mass index and systolic blood pressure were conducted, the risk still remained statistically significant (HR 1.74, CI 1.16 to 2.63, p<0.01). Statistical significance disappeared with further adjustment for QUICKI.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Liver fat content increases the risk of future cardiovascular disease event in long-term follow-up but it is seems to be dependent on insulin sensitivity.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pisto</LastName>
<ForeName>Pauliina</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine and Biocenter Oulu, Institute of Clinical Medicine, University of Oulu, and Clinical Research Center, Oulu University Hospital, Oulu, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Santaniemi</LastName>
<ForeName>Merja</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Bloigu</LastName>
<ForeName>Risto</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ukkola</LastName>
<ForeName>Olavi</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kesäniemi</LastName>
<ForeName>Y Antero</ForeName>
<Initials>YA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>03</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>BMJ Open</MedlineTA>
<NlmUniqueID>101552874</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2011;343:d6891</RefSource>
<PMID Version="1">22102439</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Hepatol. 2012 Jan;56(1):234-40</RefSource>
<PMID Version="1">21703178</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur Heart J. 2012 May;33(10):1190-200</RefSource>
<PMID Version="1">22408036</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Gastroenterol Hepatol. 2012 Jun;10(6):646-50</RefSource>
<PMID Version="1">22245962</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Liver Int. 2012 Jul;32(6):945-50</RefSource>
<PMID Version="1">22299674</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Opin Cardiol. 2012 Jul;27(4):420-8</RefSource>
<PMID Version="1">22596186</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Prev Cardiol. 2014 Oct;21(10):1242-8</RefSource>
<PMID Version="1">23787794</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2010 Sep;52(3):1156-61</RefSource>
<PMID Version="1">20658466</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2010 Sep 30;363(14):1341-50</RefSource>
<PMID Version="1">20879883</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circulation. 2011 Feb 1;123(4):e18-e209</RefSource>
<PMID Version="1">21160056</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Alcohol Alcohol. 2011 Mar-Apr;46(2):113-6</RefSource>
<PMID Version="1">21245063</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Obesity (Silver Spring). 2011 Apr;19(4):848-52</RefSource>
<PMID Version="1">20966903</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2011 Jul;54(1):145-52</RefSource>
<PMID Version="1">21488080</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Cardiol Rep. 2011 Aug;13(4):287-95</RefSource>
<PMID Version="1">21556974</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Metabolism. 2011 Nov;60(11):1515-20</RefSource>
<PMID Version="1">21565369</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gut. 2011 Dec;60(12):1721-7</RefSource>
<PMID Version="1">21602530</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Endocrinol Metab. 2000 Jul;85(7):2402-10</RefSource>
<PMID Version="1">10902785</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2002 Apr 18;346(16):1221-31</RefSource>
<PMID Version="1">11961152</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 2002 May 15;287(19):2570-81</RefSource>
<PMID Version="1">12020339</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Gastroenterol Hepatol. 2003 May;15(5):539-43</RefSource>
<PMID Version="1">12702913</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gut. 2004 May;53(5):750-5</RefSource>
<PMID Version="1">15082596</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Tohoku J Exp Med. 1983 Jan;139(1):43-50</RefSource>
<PMID Version="1">6220488</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Hypertens. 1998 Nov;11(11 Pt 1):1334-43</RefSource>
<PMID Version="1">9832177</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Intern Med. 1999 Feb;245(2):163-74</RefSource>
<PMID Version="1">10081519</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2005 May;25(5):1045-50</RefSource>
<PMID Version="1">15731489</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Diabet Med. 2005 Oct;22(10):1354-8</RefSource>
<PMID Version="1">16176196</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circulation. 2005 Oct 4;112(14):2130-7</RefSource>
<PMID Version="1">16186419</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Diabetes. 2005 Dec;54(12):3541-6</RefSource>
<PMID Version="1">16306373</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2006 Oct;44(4):865-73</RefSource>
<PMID Version="1">17006923</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2006 Dec 14;444(7121):875-80</RefSource>
<PMID Version="1">17167476</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2006 Dec 14;444(7121):881-7</RefSource>
<PMID Version="1">17167477</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Atherosclerosis. 2007 Apr;191(2):235-40</RefSource>
<PMID Version="1">16970951</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2007 Mar 14;13(10):1579-84</RefSource>
<PMID Version="1">17461452</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2729-35</RefSource>
<PMID Version="1">17932318</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Hepatol. 2008 Oct;49(4):600-7</RefSource>
<PMID Version="1">18672311</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Diabetologia. 2008 Nov;51(11):1947-53</RefSource>
<PMID Version="1">18762907</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Gastroenterol. 2008 Sep;103(9):2263-71</RefSource>
<PMID Version="1">18684196</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Sci (Lond). 2008 Jul;115(1):1-12</RefSource>
<PMID Version="1">19016656</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2009 Nov;50(5):1403-11</RefSource>
<PMID Version="1">19670414</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Hepatol. 2009 Dec;51(6):1061-7</RefSource>
<PMID Version="1">19846234</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2010 Feb;51(2):595-602</RefSource>
<PMID Version="1">20014114</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Endocrinol Metab. 2010 May;95(5):2467-75</RefSource>
<PMID Version="1">20332251</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E462-8</RefSource>
<PMID Version="1">15339742</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2005 Apr 21;352(16):1685-95</RefSource>
<PMID Version="1">15843671</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D002318">Cardiovascular Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D015994">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D053208">Kaplan-Meier Estimate</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D065626">Non-alcoholic Fatty Liver Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000736">ultrasonography</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011159">Population Surveillance</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC3963104</OtherID>
<GeneralNote Owner="NLM">Original DateCompleted: 20140321</GeneralNote>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pii">bmjopen-2014-004973</ArticleId>
<ArticleId IdType="doi">10.1136/bmjopen-2014-004973</ArticleId>
<ArticleId IdType="pubmed">24650811</ArticleId>
<ArticleId IdType="pmc">PMC3963104</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/OperaV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000169 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000169 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Musique
   |area=    OperaV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:24650811
   |texte=   Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:24650811" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a OperaV1

This area was generated with Dilib version V0.6.21.
Data generation: Thu Apr 14 14:59:05 2016. Site generation: Thu Jan 4 23:09:23 2024

	Serveur d'exploration sur l'opéra
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur l'opéra

Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study.

Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study.

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki